Skip to main content

Table 1 Quality assessment of the included studies

From: Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis

References JBI’s critical appraisal checklist, 2017
Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11
Mohammednur et al. 2014 [45] Yes Yes No yes No No Yes No NA NA NA
Gebre et al. 2017 [34] Yes yes No Yes Yes Yes Yes Yes NA NA NA
Gobezie et al. 2014 [46] Yes Yes No Yes No Yes Yes Yes NA NA NA
Gobezie et al. 2013 [24] Yes No No Yes Yes Yes Yes UC Yes No Yes
Aster et al. 2019 [26] Yes No No Yes Yes Yes Yes UC Yes No Yes
Yaschilal et al. 2014 [43] Yes No No Yes Yes Yes Yes UC Yes No NA
Abadir et al. 2015 [47] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Gashaw et al. 2016 [54] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Yirga et al. 2015 [27] Yes No No Yes Yes Yes Yes UC Yes No Yes
Tamene et al. 2014 [28] Yes No No Yes Yes Yes Yes UC Yes No Yes
Bereket et al. 2014 [29] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Mohammed et al. 2016 [30] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Mequanent et al. 2014 [55] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Asgedom et al. 2016 [48] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Kaleab et al. 2015 [49] Yes Yes No Yes Yes No Yes No NA NA NA
Eskinder et al. 2013 [33] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Hailu et al. 2015 [50] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Malede et al. 2018 [36] Yes No No Yes Yes Yes Yes UC Yes No Yes
Beshir et al. 2017 [37] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Elham et al. 2017 [25] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Mohammed et al. 2014 [38] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Tadele et al. 2015 [53] Yes No No Yes Yes Yes Yes UC Yes No Yes
Ayele et al. 2017 [41] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Tamene et al. 2017 [28] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Haymen et al. 2018 [40] Yes Yes No Yes Yes Yes Yes No NA NA NA
Berhane et al. 2017 [31] Yes No No Yes Yes Yes Yes UC Yes No Yes
Gobezie et al. 2013 [50] Yes Yes No Yes Yes Yes Yes Yes Yes No Yes
Yohannes et al. 2017 [41] Yes Yes No Yes Yes No Yes No NA NA NA
Bereket et al. 2013 [32] Yes Yes No Yes Yes Yes Yes Yes NA NA NA
Gizachew et al. 2018 [44] Yes No No Yes Yes Yes Yes UC Yes No Yes
Gubae et al. 2017 [39] Yes Yes No Yes Yes No Yes Yes NA NA NA
Gosaye et al. [33] Yes No No Yes Yes Yes Yes UC Yes No Yes
  1. NA not applicable, UC-unclear; Q1-11, JBI's Critical Appraisal Checklist for Cohort studies [Q1: Were the two groups similar and recruited from the same population? Q2: Were the exposures measured similarly to assign people to both exposed and unexposed groups? Q3: Was the exposure measured in a valid and reliable way? Q4: Were confounding factors identified? Q5: Were strategies to deal with confounding factors stated? Q6: Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? Q7: Were the outcomes measured in a valid and reliable way? Q8: Was the follow-up time reported and sufficient to be long enough for outcomes to occur? Q9: Was follow up complete, and if not, were the reasons to loss to follow up described and explored? Q10: Were strategies to address incomplete follow up utilized? Q11: Was appropriate statistical analysis used?]; Q1-8, JBI's Critical Appraisal Checklist for Analytical Cross-Sectional studies [Q1: Were the criteria for inclusion in the sample clearly defined? Q2: Were the study subjects and the setting described in detail? Q3: Was the exposure measured in a valid and reliable way? Q4: Were objective, standard criteria used for measurement of the condition? Q5: Were confounding factors identified? Q6: Were strategies to deal with confounding factors stated? Q7: Were the outcomes measured in a valid and reliable way? Q8: Was an appropriate statistical analysis used?]